• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

AGA technical review on nonalcoholic fatty liver disease.

作者信息

Sanyal Arun J

机构信息

Department of Internal Medicine Virginia Commonwealth University Medical College of Virginia Richmond, Virginia, USA.

出版信息

Gastroenterology. 2002 Nov;123(5):1705-25. doi: 10.1053/gast.2002.36572.

DOI:10.1053/gast.2002.36572
PMID:12404245
Abstract
摘要

相似文献

1
AGA technical review on nonalcoholic fatty liver disease.美国胃肠病学会关于非酒精性脂肪性肝病的技术审查
Gastroenterology. 2002 Nov;123(5):1705-25. doi: 10.1053/gast.2002.36572.
2
Nonalcoholic fatty liver disease: is all the fat bad?非酒精性脂肪性肝病：所有的脂肪都有害吗？
Intern Med J. 2004 Apr;34(4):187-91. doi: 10.1111/j.1444-0903.2004.00574.x.
3
Nonalcoholic fatty liver disease.非酒精性脂肪性肝病
N Engl J Med. 2002 Apr 18;346(16):1221-31. doi: 10.1056/NEJMra011775.
4
Nonalcoholic fatty liver disease.非酒精性脂肪性肝病
Gastroenterology. 2002 May;122(6):1649-57. doi: 10.1053/gast.2002.33573.
5
[Alcohol and fatty liver].
Internist (Berl). 1968 Jun;9(6):247-55.
6
Nonalcoholic fatty liver disease.非酒精性脂肪性肝病
CMAJ. 2005 Mar 29;172(7):899-905. doi: 10.1503/cmaj.045232.
7
Nonalcoholic fatty liver disease.
Nurse Pract. 2007 Feb;32(2):24-5. doi: 10.1097/00006205-200702000-00002.
8
Nonalcoholic fatty liver disease: diagnosis and management.非酒精性脂肪性肝病：诊断与管理。
Am Fam Physician. 2013 Jul 1;88(1):35-42.
9
Nonalcoholic fatty liver disease.非酒精性脂肪性肝病
Am Fam Physician. 2006 Jun 1;73(11):1961-8.
10
[Current knowledge of nonalcoholic steatohepatitis].
Med Clin (Barc). 2003 Jun 21;121(3):102-8. doi: 10.1016/s0025-7753(03)73870-6.

引用本文的文献

1
The utility of an artificial intelligence model based on decision tree and evolution algorithm to evaluate steatotic liver disease in a primary care setting.一种基于决策树和进化算法的人工智能模型在基层医疗环境中评估脂肪性肝病的效用。
Braz J Med Biol Res. 2025 Jun 16;58:e14538. doi: 10.1590/1414-431X2025e14538. eCollection 2025.
2
Attenuation Based Quantitative Evaluation of Hepatic Steatosis Using US: Current Status and Future Perspective.基于衰减的肝脏脂肪变性超声定量评估：现状与未来展望
J Korean Soc Radiol. 2025 May;86(3):321-334. doi: 10.3348/jksr.2025.0024. Epub 2025 May 26.
3
Correlation Between Liver-to-Spleen Hounsfield Unit Ratio and Metabolic Improvement in Patients With Bariatric Surgery.
减重手术患者肝脏与脾脏Hounsfield单位比值与代谢改善的相关性
J Metab Bariatr Surg. 2025 Apr;14(1):24-31. doi: 10.17476/jmbs.2025.14.1.24. Epub 2025 Apr 10.
4
Increased Mortality Associated with Amiodarone Compared to Other Antiarrhythmic Drugs in New-Onset Atrial Fibrillation.与其他抗心律失常药物相比，胺碘酮在新发房颤中导致死亡率增加。
J Clin Med. 2025 Feb 11;14(4):1168. doi: 10.3390/jcm14041168.
5
Two faces of the same coin non alcoholic fatty liver disease; with and without diabetes: Comparative clinico pathological analysis: A cross sectional observational study.同一硬币的两面：非酒精性脂肪性肝病；伴糖尿病和不伴糖尿病：比较临床病理分析：一项横断面观察性研究
J Family Med Prim Care. 2025 Jan;14(1):56-61. doi: 10.4103/jfmpc.jfmpc_1208_23. Epub 2025 Jan 13.
6
Elevated serum neprilysin levels in patients with chronic hepatitis C and metabolic dysfunction-associated steatotic liver disease: hepatic oxidative stress as an underlying mechanism.慢性丙型肝炎和代谢功能障碍相关脂肪性肝病患者血清中性肽链内切酶水平升高：肝脏氧化应激作为潜在机制
Mol Biol Rep. 2024 Dec 26;52(1):81. doi: 10.1007/s11033-024-10152-0.
7
Interplay among IL1R1, gut microbiota, and bile acids in metabolic dysfunction-associated steatotic liver disease: a comprehensive review.白细胞介素1受体1、肠道微生物群和胆汁酸在代谢功能障碍相关脂肪性肝病中的相互作用：综述
J Gastroenterol Hepatol. 2025 Jan;40(1):33-40. doi: 10.1111/jgh.16750. Epub 2024 Sep 29.
8
FIB-4 Index and Liver Stiffness Measurement are Potential Predictors of Atherosclerosis in Metabolic Dysfunction-Associated Steatotic Liver Disease.FIB-4指数和肝脏硬度测量是代谢功能障碍相关脂肪性肝病中动脉粥样硬化的潜在预测指标。
J Atheroscler Thromb. 2025 Feb 1;32(2):239-252. doi: 10.5551/jat.64809. Epub 2024 Sep 4.
9
Self-management in patients with metabolic dysfunction-associated steatotic liver disease: influencing factors and impact on readmission.代谢功能障碍相关脂肪性肝病患者的自我管理：影响因素及其对再入院的影响。
J Health Popul Nutr. 2024 Aug 31;43(1):134. doi: 10.1186/s41043-024-00618-z.
10
Glucagon promotes increased hepatic mitochondrial oxidation and pyruvate carboxylase flux in humans with fatty liver disease.胰高血糖素促进脂肪性肝病患者肝脏线粒体氧化和丙酮酸羧化酶通量增加。
Cell Metab. 2024 Nov 5;36(11):2359-2366.e3. doi: 10.1016/j.cmet.2024.07.023. Epub 2024 Aug 27.